The IPOX® Week, April 26th, 2021

  • IPOX® 100 U.S. (ETF: FPX) outpaces Nasdaq 100. Smoother sailing for China-linked exposure, strong Europe propels IPOX® International (ETF: FPXI).
  • BioNTech closes valuation gap with Moderna further.
  • IPOX® SPAC (SPAC) adds +0.23% as sentiment recovers, pretzel maker Utz (UTZ US: +6.67%) jumps to all-time high.
  • Track global deal flow here: https://ipox.com/ipox-deals/

Summary: Big gyrations in U.S. equities on U.S. tax plans amid higher risk (VIX: +6.65%), lower U.S. yields and earnings did little to derail the overall positive sentiment in the IPOX® Indexes towards month-end. In the U.S., e.g., the IPOX® 100 U.S. (ETF: FPX), underlying for the $BN 2.1 FPX ETF, declined -0.39% to +6.76% YTD, outperforming the Nasdaq 100, while slightly lagging the S&P 500 (SPX) last week. Sentiment was better for non-U.S. domiciled stocks, with the IPOX® International, tracked by the $BN 1.2 FPXI ETF, adding +1.10% to -0.28% YTD, significantly ahead of the benchmarks. Here, strength was driven by gains in the IPOX China (CNI) and in the IPOX® 100 Europe (ETF: FPXE), which continued its march towards an all-time high with a gain of +0.36% to +3.60% YTD, outpacing the benchmarks.

IPOX® International Investing with the FPXI ETF since 2015:

Key FPXI and FPXE ETF portfolio holding German Covid-19 vaccine maker BioNTech (BNTX US: +14.16% and +112.22% YTD) continued to lead the list of best IPOX® performers, as the stock – untracked by the major benchmarks including the Nasdaq 100 (NDX) – continued to close its valuation gap with U.S. counterpart Moderna (MRNA US: +1.57% and +66.20% YTD). We also note Friday’s fresh all-time high in NY-based pretzel maker $BN 3.8 Utz Brands (UTZ US: +6.67%), one of four demerged SPACs currently tracked in the IPOX® 100 U.S. (ETF: FPX). The stock continued to dodge some of the negative sentiment linked to (demerged) SPACs and rose to +24.03% YTD, driven by upgrades, growth- and corporate actions optimism. After the big run-up, select Nordic-domiciled exposure fell sharply last week, including Stockholm-based private equity firm EQT (EQT SS: -8.54%), cloud communication platform operator Softbank-backed Sinch (SINCH SS: -6.78%), digital wealth management company 11/2020 IPO Nordnet (SAVE SS: -5.23%) and video games developer Embracer Group (EMBRACB SS: -3.30%).

Select IPOX® Indexes Price Returns (%) 2020 Last Week YTD
IPOX® Indexes: Global/International
IPOX® Global Super Liquid (IPGL50) (USD) 66.63 0.72 3.50
IPOX® International (IPXI) (USD) (ETF : FPXI) 72.15 1.10 -0.28
IPOX® Indexes: United States
IPOX® 100 U.S. (IPXO)* (USD) (ETF: FPX) 47.32 -0.39 6.76
IPOX® ESG (IPXT) (USD) 42.29 0.43 6.12
IPOX® SPAC (SPAC) (USD)** 48.52 0.23 -1.95
IPOX® Indexes: Europe/Nordic
IPOX® 100 Europe (IPOE) (USD) (ETF: FPXE) 35.14 0.36 3.60
IPOX® Nordic Core (IPND) (EUR) 59.89 -1.94 14.15
IPOX® Indexes: Asia-Pacific/China
IPOX® Asia-Pacific (IPTA) (USD) 47.50 -0.25 1.79
IPOX® China Core (CNI) (USD) 88.02 4.28 -2.97
IPOX® Japan (IPJP)(JPY) 25.75 -1.04 2.20

* Basis for CME-traded e-mini IPOX® 100 U.S. Futures (IPOM1).

The IPOX® SPAC Index (SPAC) added +0.23% to -1.95% YTD and +45.64% since its 7/30/2020 launch. News include: 1) 3 SPACs Announced Merger Agreements include: a) Horizon Acquisition with Vivid Seats; b) Fifth Wall Acquisition I with SmartRent; and c) Roman DBDR Tech Acquisition with CompoSecure. 2) 3 SPACs Approved Business Combination include: a) Northern Genesis with Lion Electric (LEV: TBA); b) GigCapital3 with Lighting eMotors (ZEV: TBA); and c) dMY Technology Group II with Genius Sports (GENI). 3) SPACs reportedly in talks include: a) SoftBank backed SVF Investment 3 with MapBox. 4) No SPAC launched last week.

IPO Deal-flow Review and Outlook: At least 21 notable IPOs launched last week with the average (median) equally weighted deal adding +23.36% (+26.81%) based on the final offer price and respective Friday’s close. In the U.S., extra-low (5%!!!) float automation platform unicorn UiPath (PATH US: +33.64%), KKR-backed cybersecurity firm KnowBe4 (KNBE US: +44.13%), biofacturing firm Zymergen (ZY US: +28.65%) and swimming pool maker Latham (SWIM US: +43.42%) all debuted successfully, while European B2B fund distributor Allfunds (ALLFG NA: +20.42%), online recruiting platform Visional (4194 JP: +30.00%) and Trip.com (9961 HK: +12.69%) all rose abroad. The hot IPO market is set to continue with pediatric home care platform Aveanna (AVAH US), talent agency and UFC owner Endeavor (EDR US), Swedish contract drugmaker PolyPeptide (PPGN SW) and German laboratory diagnostics provider Synlab (SYAB GR) set to go public. In other IPO news: 1) oat milk maker Oatly, LinkedIn-backed event streaming platform Confluent and Peter Thiel-backed psychedelic drug developer Atai file for IPO; 2) social media message platform Discord rejects Microsoft’s bid to pursue IPO; 3) foreign deals in the pipeline include U.K. cybersecurity firm Darktrace, German online car retailer MeinAuto, French cloud-computing firm OVH and Saudi exchange Saudi Tadawul Group.

Lightspeed Financial Services Group LLC is not affiliated with these third-party market commentators/educators or service providers. Data, information, and material (“content”) are provided for informational and educational purposes only. This content neither is, nor should be construed as an offer, solicitation, or recommendation to buy or sell any securities or contracts. Any investment decisions made by the user through the use of such content is solely based on the users independent analysis taking into consideration your financial circumstances, investment objectives, and risk tolerance. Lightspeed Financial Services Group LLC does not endorse, offer nor recommend any of the services or commentary provided by any of the market commentators/educators or service providers and any information used to execute any trading strategies are solely based on the independent analysis of the user.

You may also be interested in...

The IPOX® Week, May 3rd, 2021
Read More
3 Red Flags Dividend Investors Should Watch
Read More
What Is the Difference Between Average Daily Trading Volume and Open Interest?
Read More
3 Top Support and Resistance Trading Strategies to Live By
Read More

Try the demo

Compare Platforms
Check the background of this firm on FINRA's BrokerCheck

Our website uses cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site in our Privacy Policy. By clicking OK, you agree to allow us to collect information through cookies.

OK